9.91

2.36% -0.24

After Hours: 10.10 0.19 +1.92%

Oruka Therapeutics Inc (ORKA)

Overview News Price History Discussions Forecast

Oruka Therapeutics Inc stock is traded at $9.91, with a volume of 197.71K. It is down -2.36% in the last 24 hours and down -27.66% over the past month. Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Previous Close:

$10.15

Open:

$10.16

24h Volume:

197.71K

Relative Volume:

0.66

Market Cap:

$346.31M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-8.75%

1M Performance:

-27.66%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$9.77

$10.89

1-Week Range:

$9.53

$11.03

52-Week Range:

$9.53

$31.13

Oruka Therapeutics Inc Stock (ORKA) Company Profile

Name

Oruka Therapeutics Inc

Sector

Healthcare (1189)

Industry

Biotechnology (682)

Phone

650-606-7910

Address

855 OAK GROVE AVE., MENLO PARK

Employee

Twitter

Next Earnings Date

2024-11-04

Latest SEC Filings

ORKA's Discussions on Twitter

Compare ORKA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ORKA Oruka Therapeutics Inc	9.91	346.31M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-04-25	Initiated	Wolfe Research	Outperform
Oct-11-24	Initiated	Stifel	Buy
Oct-07-24	Initiated	H.C. Wainwright	Buy
Sep-17-24	Initiated	Leerink Partners	Outperform
Sep-16-24	Initiated	TD Cowen	Buy
Sep-13-24	Initiated	Jefferies	Buy
Feb-27-18	Initiated	Ascendiant Capital Markets	Buy
Oct-09-13	Initiated	Dawson James	Buy

View All

Oruka Therapeutics Inc Stock (ORKA) Latest News

Feb 28, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Major Shareholder Acquires $106,396.06 in Stock - MarketBeat

Feb 28, 2025

Insider Buying: Oruka Therapeutics, Inc. (NASDAQ:ORKA) Major Shareholder Acquires 88,794 Shares of Stock - MarketBeat

Feb 28, 2025

Feb 27, 2025

Oruka Therapeutics sees $1.41 million in stock purchases by Venrock - Investing.com Canada

Feb 27, 2025

Oruka Therapeutics sees $1.41 million in stock purchases by Venrock Healthcare - Investing.com

Feb 27, 2025

Feb 22, 2025

Oruka Therapeutics (ORKA) to Release Earnings on Thursday - Defense World

Feb 22, 2025

Feb 20, 2025

Contrasting Virax Biolabs Group (NASDAQ:VRAX) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Feb 20, 2025

Feb 19, 2025

Oruka Therapeutics to Present at Multiple March Investor Conferences - GlobeNewswire

Feb 19, 2025

Can This Clinical-Stage Biotech's March Conference Circuit Signal Major Developments? - StockTitan

Feb 19, 2025

Feb 17, 2025

Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World

Feb 17, 2025

Feb 15, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Feb 15, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Feb 15, 2025

Feb 11, 2025

HC Wainwright Reaffirms Buy Rating for Oruka Therapeutics (NASDAQ:ORKA) - MarketBeat

Feb 11, 2025

Feb 10, 2025

Financial Fitness Check: Examining Oruka Therapeutics Inc (ORKA)’s Key Ratios - The Dwinnex

Feb 10, 2025